Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Regina Elena Cancer Institute

Home Clinical Trial Sponsors and OrganizationsRegina Elena Cancer Institute

Regina Elena Cancer Institute

ACTIVE

ItalyPrivate

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

93

10 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

26

28.0%

Phase 2

7

7.5%

Phase 3

2

2.1%

Phase 4

1

1.1%

Trial Status Distribution

Active, not recruiting

9

9.7%

Completed

20

21.5%

Not yet recruiting

1

1.1%

Recruiting

55

59.1%

Unknown

8

8.6%

Clinical Trials

Trials sponsored by this organization (93)

Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt

Active, not recruiting

Aug 2026236 participants

Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis

Sep 2025134 participants

Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway

Sep 202570 participants

Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy

Aug 202582 participants

Standardization of a Platform of Preclinical Models Derived From NSCLC Patients

Jul 20255 participants

Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy

Mar 202524 participants

Generation of Endometrial Carcinoma Organoids

Mar 202520 participants

Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

Jan 202520 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials93
Approvals
News

Back to Organizations